Jean‐Noël Fiessinger

Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial

Kim-Thanh Ong, Jérôme Perdu, Julie De Backer et al. · The Lancet · 2010 · 403 citations

Medicine, Pharmacology, Pharmacotherapy +8

Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein Thrombosis

Jean‐Noël Fiessinger, Menno V. Huisman, Bruce L. Davidson et al. · JAMA · 2005 · 296 citations

Medicine, Hematology, Pharmacology +17

Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans

Jean‐Noël Fiessinger, Michael Schäfer · The Lancet · 1990 · 287 citations

Medicine, Pharmacotherapy, Surgery +13

The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers–Danlos syndrome

Michael Frank, Juliette Albuisson, Brigitte Ranque et al. · European Journal of Human Genetics · 2015 · 239 citations · Full text

Life Sciences, Genetics, Molecular Genetics +9

P2Y ₁₂ H2 Haplotype Is Associated With Peripheral Arterial Disease

Pierre Fontana, Pascale Gaussem, Martine Aiach et al. · Circulation · 2003 · 164 citations · Full text

Medicine, Hematology, Cardiovascular Genetics +16